Parametric dynamic F-18-FDG PET/CT breast imaging

This study was undertaken to estimate metabolic tissue properties from dynamic breast F-18-FDG PET/CT image series and to display them as 3D parametric images. Each temporal PET series was obtained immediately after injection of 10 mCi of F-18-FDG and consisted of fifty 1- minute frames. Each consecutive frame was nonrigidly registered to the first frame using a finite element method (FEM) based model and fiducial skin markers. Nonlinear curve fitting of activity vs. time based on a realistic two-compartment model was performed for each voxel of the volume. Curve fitting was accomplished by application of the Levenburg-Marquardt algorithm (LMA) that minimized X2. We evaluated which parameters are most suitable to determine the spatial extent and malignancy in suspicious lesions. In addition, Patlak modeling was applied to the data. A mixture model was constructed and provided a classification system for the breast tissue. It produced unbiased estimation of the spatial extent of the lesions. We conclude that nonrigid registration followed by voxel-by-voxel based nonlinear fitting to a realistic two-compartment model yields better quality parametric images, as compared to unprocessed dynamic breast PET time series. By comparison with the mixture model, we established that the total cumulated activity and maximum activity parametric images provide the best delineation of suspicious breast tissue lesions and hyperactive subregions within the lesion that cannot be discerned in unprocessed images.

[1]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  M. Echenique,et al.  Evaluation of Breast Imaging Reporting and Data System Category 3 mammograms and the use of stereotactic vacuum‐assisted breast biopsy in a nonacademic community practice , 2004, Cancer.

[3]  Alexander S. Rosemurgy,et al.  One Hundred Consecutive Advanced Breast Biopsy Instrumentation Procedures: Complications, Costs, and Outcome , 1999, Annals of Surgical Oncology.

[4]  E. Bombardieri,et al.  PET imaging in breast cancer. , 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[5]  T. Tong,et al.  Cancer statistics, 1994 , 1994, CA: a cancer journal for clinicians.

[6]  S. Heiba,et al.  The Distinctive Role of Positron Emission Tomography/Computed Tomography in Breast Carcinoma with Brown Adipose Tissue 2‐Fluoro‐2‐Deoxy‐D‐Glucose Uptake , 2005, The breast journal.

[7]  R L Wahl,et al.  Current status of PET in breast cancer imaging, staging, and therapy. , 2001, Seminars in roentgenology.

[8]  Michèle Allard,et al.  A method to quantify the uptake rate of 2-[18F]fluoro-2-deoxy-D-glucose in tissues. , 2004, Nuclear medicine communications.

[9]  J. Burkhardt,et al.  Core-needle and surgical breast biopsy: comparison of three methods of assessing cost. , 1999, Radiology.

[10]  H. Biersack,et al.  Breast cancer imaging with PET and SPECT agents: an in vivo comparison. , 2002, Nuclear medicine and biology.

[11]  Peters Am,et al.  Graphical analysis of dynamic data: the Patlak-Rutland plot. , 1994 .

[12]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  C J Baines,et al.  Menstrual cycle variation in mammographic breast density: so who cares? , 1998, Journal of the National Cancer Institute.

[14]  Finbarr O'Sullivan,et al.  Imaging radiotracer model parameters in PET: a mixture analysis approach , 1993, IEEE Trans. Medical Imaging.

[15]  K. Scheidhauer,et al.  FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions , 2004, European Journal of Nuclear Medicine and Molecular Imaging.